Skip to main navigation
Skip to content
C4 Therapeutics

Main navigation

  • Who We Are Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Research & Technology Expand
    • Targeted Protein Degradation
    • C4T TORPEDO™ Platform
    • aTAG Open Source Program
  • Pipeline
  • Partnerships
  • News
  • Investors Expand
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
  • Careers Expand
    • Culture @ C4T
    • Benefits
    • Current Openings
C4 Therapeutics

SEC Filing Details

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ
Menu

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 11, 2021
Document Date
Dec 31, 2020
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
C4 Therapeutics
Issuer
C4 Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Toolkit

Who We Are

  • Overview
  • Leadership
  • Board of Directors
  • Scientific Advisory Board

Research & Technology

  • Targeted Protein Degradation
  • C4T TORPEDO™ Platform
  • Partnerships & Collaborations
  • aTAG Open Source Program

Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ

Careers

  • Culture
  • Benefits
  • Current Openings

Social

Linkedin Twitter

© C4 Therapeutics, 2021. All Rights Reserved.   |   Contact Us

Legal

Privacy Policy   |   Terms of Use Agreement   |   Sitemap
logo-fierce15_medtech
logo-bwwc
logo-top-places-to-work
Scroll to top
Search

Main navigation

  • Who We Are
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Research & Technology
    • Targeted Protein Degradation
    • C4T TORPEDO™ Platform
    • aTAG Open Source Program
  • Pipeline
  • Partnerships
  • News
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
  • Careers
    • Culture @ C4T
    • Benefits
    • Current Openings

Search